Neopharma in major investment
May 22, 2017
UAE pharmaceutical manufacturing frim Neopharma has in vested Dh100 million in the acquisition of patents and licences and an aditional investment in clinical studies amounting to DH515 million. The Factory in Japan will manufacture supplements for patients in the pre-diabetic stage and also Type-II diabetic patients.